Zydus received FDA approval to conduct a Phase 2b trial testing usnoflast, its oral therapy for ALS, in 210 patients.
Hosted on MSN1mon
Aurobindo Pharma, Glenmark recall products in USDrug makers Aurobindo Pharma, Glenmark and Zydus are recalling products in the ... bottles of Diltiazem Hydrochloride extended-release capsules (multiple strengths) in the US market.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback